Treatment options for thyroid cancer: an interview with Kate Newbold
Jan 10, 2022•10 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Find out about current treatment options for thyroid cancer such as the recent approval of selpercatinib for patients with an alteration in the RET gene in this interview with Kate Newbold who is a clinical oncologist consultant at The Royal Marsden Hospital in London (UK).
For the best experience, listen in Metacast app for iOS or Android
Open in Metacast